Pareto and Analysguiden publish research reports
Hørsholm, Denmark, 16 March 2023 – ExpreS2ion Biotech Holding AB’s affiliate ExpreS2ion Biotechnologies ApS (“ExpreS2ion") announces that Pareto Securities and Analysguiden have both published research reports on ExpreS2ion in March. Both sponsored research analysts commented on the recently announced rights issue and MucoVax collaboration. Analysguiden reduced its price target to SEK 12 per share, primarily a result of dilution from the rights issue and updates to its estimates for ABNCoV2, the COVID-19 vaccine candidate.The Analysguiden report dives deeper into recent topics related to